Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Buy AFYA Stock  Free AFYA Stock Alerts

Afya (AFYA) Financials

Afya logo
$18.16 -0.15 (-0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$18.16 0.00 (-0.01%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Afya

Annual Income Statements for Afya

This table shows Afya's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Net Income / (Loss) Attributable to Common Shareholders		 102 80 71 84 56 -59 22 14
Consolidated Net Income / (Loss)		 105 84 74 43 59 43 24 15
Net Income / (Loss) Continuing Operations		 105 84 74 43 59 -59 24 15
Total Pre-Tax Income 		109 89 81 49 65 -59 25 15
Total Operating Income		 164 158 126 79 70 -59 25 15
Total Gross Profit		 338 364 278 191 148 110 43 28
Total Revenue		 534 593 441 308 231 0.65 86 65
Operating Revenue		 534 593 441 308 231 0.65 86 65
Total Cost of Revenue		 197 229 163 117 84 0.00 43 37
Operating Cost of Revenue		 197 229 163 117 84 - 43 37
Total Operating Expenses		 174 206 152 112 78 59 18 14
Selling, General & Admin Expense		 173 209 151 112 78 59 18 14
Other Operating Expenses / (Income)		 1.18 -3.22 1.37 0.64 0.07 - -0.15 -
Total Other Income / (Expense), net		 -56 -72 -47 -32 -6.93 0.00 0.59 0.49
Interest Expense		 74 94 66 44 19 - 2.10 1.08
Interest & Investment Income		 18 23 19 12 12 - 2.69 1.58
Other Income / (Expense), net		 1.90 1.96 2.30 2.12 1.48 - 0.00 0.83
Income Tax Expense		 4.44 4.98 6.75 5.59 5.21 - 1.03 0.75
Net Income / (Loss) Attributable to Noncontrolling Interest		 -2.82 -3.93 -3.63 -3.40 -3.06 - -2.16 -0.93
Basic Earnings per Share		 $1.13 $4.30 $4.14 $2.39 $3.15 - $1.84 $1.41
Weighted Average Basic Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 - -
Diluted Earnings per Share		 $1.12 $4.27 $4.12 $2.37 $3.12 - $1.81 $1.41
Weighted Average Diluted Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 - -
Weighted Average Basic & Diluted Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 - -

Quarterly Income Statements for Afya

No quarterly income statements for Afya are available.

Annual Cash Flow Statements for Afya

This table details how cash moves in and out of Afya's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Net Change in Cash & Equivalents		 101 -89 136 220 20 219 0.22 0.33
Net Cash From Operating Activities		 71 -31 64 103 64 296 1.89 0.67
Net Cash From Continuing Operating Activities		 71 -31 64 103 64 296 1.89 0.67
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense		 54 60 39 28 - - 2.34 1.21
Non-Cash Adjustments To Reconcile Net Income		 15 -87 26 76 64 296 -0.43 -0.34
Changes in Operating Assets and Liabilities, net		 2.93 -3.16 -0.42 -0.42 - - -0.02 -0.21
Net Cash From Investing Activities		 0.00 0.00 0.00 0.00 -194 -74 0.00 0.00
Net Cash From Continuing Investing Activities		 0.00 0.00 0.00 0.00 -194 -74 0.00 0.00
Net Cash From Financing Activities		 30 -58 72 117 159 -30 -1.67 -0.34
Net Cash From Continuing Financing Activities		 30 -58 72 117 159 -30 -1.67 -0.34
Repayment of Debt		 -21 -23 -0.34 -19 -30 -19 - -
Issuance of Debt		 79 1.09 94 145 116 1.84 - 0.00
Other Financing Activities, net		 -29 -36 -22 -9.02 - - -1.67 -0.34

Quarterly Cash Flow Statements for Afya

No quarterly cash flow statements for Afya are available.

Annual Balance Sheets for Afya

This table presents Afya's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Total Assets		 1,428 1,563 1,362 1,157 923 725 237
Total Current Assets		 257 248 310 216 271 277 34
Cash & Equivalents		 147 114 207 134 201 235 16
Accounts Receivable		 96 113 86 68 58 31 15
Current Deferred & Refundable Income Taxes		 4.16 9.02 5.26 4.59 4.05 1.61 0.58
Other Current Assets		 9.24 12 9.79 7.63 5.70 4.46 2.28
Plant, Property, & Equipment, net		 106 125 103 75 50 35 17
Plant, Property & Equipment, gross		 106 125 103 75 50 35 17
Total Noncurrent Assets		 1,058 1,182 942 860 537 413 185
Long-Term Investments		 8.80 11 10 8.70 9.90 11 0.00
Intangible Assets		 895 988 765 700 495 327 176
Other Noncurrent Operating Assets		 155 182 167 151 31 73 8.11
Total Liabilities & Shareholders' Equity		 1,428 1,563 1,362 1,157 923 725 237
Total Liabilities		 731 812 747 618 377 199 85
Total Current Liabilities		 184 218 125 137 113 83 47
Short-Term Debt		 59 37 27 23 21 13 6.91
Accounts Payable		 51 22 63 11 43 4.39 2.09
Customer Deposits		 26 32 25 21 12 9.17 3.54
Current Deferred & Payable Income Tax Liabilities		 0.69 0.80 3.06 2.09 0.88 0.80 0.07
Current Employee Benefit Liabilities		 34 40 - 24 15 - 8.24
Other Current Liabilities		 9.12 81 6.65 50 13 39 23
Total Noncurrent Liabilities		 546 594 570 481 264 116 38
Long-Term Debt		 296 334 340 237 98 1.68 13
Capital Lease Obligations		 151 173 139 124 74 65 0.00
Other Noncurrent Operating Liabilities		 63 48 53 79 0.74 42 23
Total Equity & Noncontrolling Interests		 697 751 673 538 546 526 152
Total Preferred & Common Equity		 690 742 663 529 536 514 129
Total Common Equity		 690 742 663 529 536 514 114
Common Stock		 379 487 449 426 447 480 113
Retained Earnings		 325 284 190 113 79 29 -
Treasury Stock		 -44 -62 - -27 0.00 - -
Other Equity Adjustments		 30 32 23 17 9.77 4.51 0.56
Noncontrolling Interest		 6.57 8.55 9.71 9.30 9.93 12 23

Quarterly Balance Sheets for Afya

No quarterly balance sheets for Afya are available.

Annual Metrics And Ratios for Afya

This table displays calculated financial ratios and metrics derived from Afya's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Growth Metrics		 - - - - - - - -
Revenue Growth		 -9.85% 34.52% 42.86% 33.37% 35,729.12% -99.25% 31.95% 0.00%
EBITDA Growth		 -0.11% 31.60% 53.36% 52.41% 221.37% -316.41% 60.49% 0.00%
EBIT Growth		 3.45% 25.10% 57.56% 13.68% 221.37% -336.78% 58.02% 0.00%
NOPAT Growth		 5.24% 29.54% 64.37% 8.97% 256.08% -272.72% 68.35% 0.00%
Net Income Growth		 25.59% 12.45% 70.97% -26.70% 37.94% 76.08% 66.79% 0.00%
EPS Growth		 27.34% 3.64% 73.84% -24.04% 0.00% 0.00% 28.37% 0.00%
Operating Cash Flow Growth		 333.90% -147.60% -37.85% 62.11% -78.51% 15,566.45% 181.76% 0.00%
Free Cash Flow Firm Growth		 358.05% -840.81% 93.94% -59.48% 53.91% -93.29% 0.00% 0.00%
Invested Capital Growth		 -10.29% 27.21% 15.42% 46.54% 48.83% 138.15% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 63.21% 61.41% 63.09% 62.06% 63.81% 17,030.73% 49.68% 42.56%
EBITDA Margin		 41.07% 37.07% 37.89% 35.30% 30.89% -9,118.20% 31.60% 25.98%
Operating Margin		 30.63% 26.67% 28.51% 25.64% 30.25% -9,118.20% 28.88% 22.84%
EBIT Margin		 30.99% 27.00% 29.04% 26.33% 30.89% -9,118.20% 28.88% 24.12%
Profit (Net Income) Margin		 19.64% 14.10% 16.86% 14.09% 25.64% 6,660.06% 28.37% 22.44%
Tax Burden Percent		 95.94% 94.37% 91.67% 88.60% 91.92% -73.04% 95.96% 95.10%
Interest Burden Percent		 66.06% 55.32% 63.35% 60.41% 90.30% 100.00% 102.36% 97.85%
Effective Tax Rate		 4.06% 5.63% 8.33% 11.40% 8.08% 0.00% 4.04% 4.90%
Return on Invested Capital (ROIC)		 13.71% 13.84% 13.00% 10.13% 13.71% -15.39% 30.13% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.34% -4.08% -1.58% -7.63% 21.21% -133.35% 48.34% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.78% -2.10% -0.73% -2.11% -2.64% 28.07% 1.96% 0.00%
Return on Equity (ROE)		 14.50% 11.74% 12.27% 8.02% 11.07% 12.68% 32.09% 0.00%
Cash Return on Invested Capital (CROIC)		 24.57% -10.11% -1.31% -27.62% -25.54% -97.10% -169.87% 0.00%
Operating Return on Assets (OROA)		 11.07% 10.94% 10.16% 7.81% 8.67% -12.24% 10.50% 0.00%
Return on Assets (ROA)		 7.02% 5.71% 5.90% 4.18% 7.20% 8.94% 10.31% 0.00%
Return on Common Equity (ROCE)		 14.34% 11.59% 12.08% 7.88% 10.84% 11.74% 24.04% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 15.20% 11.26% 11.21% 8.22% 11.07% 8.37% 18.87% 0.00%
Net Operating Profit after Tax (NOPAT)		 157 149 115 70 64 -41 24 14
NOPAT Margin		 29.39% 25.17% 26.14% 22.72% 27.80% -6,382.74% 27.72% 21.72%
Net Nonoperating Expense Percent (NNEP)		 12.37% 17.91% 14.58% 17.76% -7.51% 117.96% -18.21% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 13.05% - - - - - - -
Cost of Revenue to Revenue		 36.79% 38.59% 36.91% 37.94% 36.19% 0.00% 50.32% 57.44%
SG&A Expenses to Revenue		 32.36% 35.28% 34.27% 36.21% 33.54% 9,218.20% 20.97% 21.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 32.58% 34.74% 34.58% 36.42% 33.57% 9,218.20% 20.79% 21.00%
Earnings before Interest and Taxes (EBIT)		 166 160 128 81 71 -59 25 16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 219 220 167 109 71 -59 27 17
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 2.13 2.77 2.17 2.77 0.00 0.73 2.29 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 1.99 0.00 0.00
Price to Revenue (P/Rev)		 2.75 3.47 3.26 4.74 0.00 577.51 3.03 4.00
Price to Earnings (P/E)		 14.39 25.81 20.35 17.52 0.00 0.00 11.73 19.05
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.95% 3.87% 4.91% 5.71% 0.00% 0.00% 8.52% 5.25%
Enterprise Value to Invested Capital (EV/IC)		 1.69 2.06 1.83 2.08 0.00 0.57 1.82 0.00
Enterprise Value to Revenue (EV/Rev)		 3.42 4.19 3.95 5.55 0.00 333.55 3.34 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 8.32 11.30 10.41 15.73 0.00 0.00 10.58 0.00
Enterprise Value to EBIT (EV/EBIT)		 11.03 15.51 13.59 21.09 0.00 0.00 11.58 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 11.63 16.64 15.09 24.45 0.00 0.00 12.07 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 25.58 0.00 27.11 16.61 0.00 0.73 152.24 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.73 0.72 0.75 0.71 0.35 0.15 0.13 0.00
Long-Term Debt to Equity		 0.64 0.68 0.71 0.67 0.32 0.13 0.09 0.00
Financial Leverage		 0.58 0.51 0.46 0.28 -0.12 -0.21 0.04 0.00
Leverage Ratio		 2.07 2.06 2.08 1.92 1.54 1.42 1.56 0.00
Compound Leverage Factor		 1.36 1.14 1.32 1.16 1.39 1.42 1.59 0.00
Debt to Total Capital		 42.05% 42.00% 43.00% 41.60% 26.15% 13.23% 11.65% 0.00%
Short-Term Debt to Total Capital		 4.89% 2.85% 2.33% 2.51% 2.79% 2.20% 4.01% 0.00%
Long-Term Debt to Total Capital		 37.16% 39.15% 40.67% 39.09% 23.35% 11.03% 7.64% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.55% 0.66% 0.82% 1.01% 1.34% 2.00% 13.23% 0.00%
Common Equity to Total Capital		 57.40% 57.34% 56.18% 57.39% 72.51% 84.78% 66.18% 0.00%
Debt to EBITDA		 2.30 2.47 3.04 3.52 2.70 -1.36 0.74 0.00
Net Debt to EBITDA		 1.59 1.91 1.74 2.21 -0.26 2.88 0.14 0.00
Long-Term Debt to EBITDA		 2.04 2.31 2.87 3.31 2.42 -1.14 0.48 0.00
Debt to NOPAT		 3.22 3.64 4.41 5.47 3.00 -1.95 0.84 0.00
Net Debt to NOPAT		 2.23 2.81 2.52 3.43 -0.29 4.12 0.16 0.00
Long-Term Debt to NOPAT		 2.85 3.40 4.17 5.14 2.68 -1.62 0.55 0.00
Altman Z-Score		 2.34 2.51 2.15 2.14 0.00 1.23 2.50 0.00
Noncontrolling Interest Sharing Ratio		 1.04% 1.28% 1.57% 1.77% 2.06% 7.42% 25.10% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 1.39 1.14 2.47 1.57 2.38 3.34 0.73 0.00
Quick Ratio		 1.32 1.04 2.33 1.47 2.29 3.21 0.67 0.00
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 281 -109 -12 -191 -120 -260 -134 0.00
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 367.92% 2,089.35% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 3.79 -1.16 -0.18 -4.37 -6.33 0.00 -63.99 0.00
Operating Cash Flow to Interest Expense		 0.96 -0.32 0.97 2.36 3.36 0.00 0.90 0.62
Operating Cash Flow Less CapEx to Interest Expense		 0.96 -0.32 0.97 2.36 2.45 0.00 0.90 0.62
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.36 0.41 0.35 0.30 0.28 0.00 0.36 0.00
Accounts Receivable Turnover		 5.11 5.98 5.74 4.89 5.17 0.03 5.71 0.00
Inventory Turnover		 0.00 176.56 73.45 65.60 69.04 0.00 150.72 0.00
Fixed Asset Turnover		 4.61 5.20 4.95 4.92 5.45 0.03 5.08 0.00
Accounts Payable Turnover		 2.69 5.36 4.42 4.35 3.52 0.00 20.74 0.00
Days Sales Outstanding (DSO)		 71.38 61.05 63.59 74.60 70.56 13,083.97 63.88 0.00
Days Inventory Outstanding (DIO)		 0.00 2.07 4.97 5.56 5.29 0.00 2.42 0.00
Days Payable Outstanding (DPO)		 135.49 68.09 82.64 83.85 103.69 0.00 17.60 0.00
Cash Conversion Cycle (CCC)		 -64.12 -4.97 -14.08 -3.68 -27.84 13,083.97 48.70 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 1,083 1,207 949 822 561 377 158 0.00
Invested Capital Turnover		 0.47 0.55 0.50 0.45 0.49 0.00 1.09 0.00
Increase / (Decrease) in Invested Capital		 -124 258 127 261 184 219 158 0.00
Enterprise Value (EV)		 1,825 2,483 1,738 1,713 0.00 215 288 0.00
Market Capitalization		 1,469 2,055 1,438 1,463 0.00 373 261 261
Book Value per Share		 $7.37 $7.92 $7.20 $5.68 $5.75 $37.39 $8.29 $0.00
Tangible Book Value per Share		 ($2.18) ($2.63) ($1.10) ($1.83) $0.43 $13.63 ($4.51) $0.00
Total Capital		 1,203 1,295 1,180 921 739 606 172 0.00
Total Debt		 506 544 507 383 193 80 20 0.00
Total Long-Term Debt		 447 507 480 360 173 67 13 0.00
Net Debt		 350 419 290 240 -18 -170 3.87 0.00
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 17 14 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -16 -47 5.11 -32 -24 -31 -22 0.00
Debt-free Net Working Capital (DFNWC)		 131 67 212 102 178 207 -5.68 0.00
Net Working Capital (NWC)		 73 30 184 79 157 194 -13 0.00
Net Nonoperating Expense (NNE)		 52 66 41 27 5.00 -84 -0.56 -0.47
Net Nonoperating Obligations (NNO)		 386 456 276 284 16 -149 6.18 0.00
Total Depreciation and Amortization (D&A)		 54 60 39 28 0.00 0.00 2.34 1.21
Debt-free, Cash-free Net Working Capital to Revenue		 -2.96% -7.96% 1.16% -10.44% -10.31% -4,851.74% -25.41% 0.00%
Debt-free Net Working Capital to Revenue		 24.61% 11.27% 48.09% 33.10% 76.86% 32,079.54% -6.60% 0.00%
Net Working Capital to Revenue		 13.61% 5.04% 41.86% 25.61% 67.94% 30,012.96% -14.62% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $1.13 $4.30 $4.14 $0.00 $3.15 $2.03 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $1.12 $4.27 $4.12 $0.00 $3.12 $2.02 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 93.72M 93.72M 93.72M 92.07M 93.15M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 157 149 115 70 64 -41 24 14
Normalized NOPAT Margin		 29.39% 25.17% 26.14% 22.72% 27.80% -6,382.74% 27.72% 21.72%
Pre Tax Income Margin		 20.47% 14.94% 18.40% 15.90% 27.89% -9,118.20% 29.56% 23.60%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 2.23 1.70 1.93 1.86 3.78 0.00 11.83 14.53
NOPAT to Interest Expense		 2.12 1.58 1.74 1.60 3.40 0.00 11.35 13.09
EBIT Less CapEx to Interest Expense		 2.23 1.70 1.93 1.86 2.86 0.00 11.83 14.53
NOPAT Less CapEx to Interest Expense		 2.12 1.58 1.74 1.60 2.48 0.00 11.35 13.09
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 4.22% 29.99% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 4.22% 29.99% 0.00% 0.00%

Quarterly Metrics And Ratios for Afya

No quarterly metrics and ratios for Afya are available.

Frequently Asked Questions About Afya's Financials

When does Afya's financial year end?

According to the most recent income statement we have on file, Afya's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Afya's net income changed over the last 7 years?

Afya's net income appears to be on an upward trend, with a most recent value of $104.94 million in 2024, rising from $14.64 million in 2017. The previous period was $83.55 million in 2023. See where experts think Afya is headed by visiting Afya's forecast page.

What is Afya's operating income?
Afya's total operating income in 2024 was $163.67 million, based on the following breakdown:
  • Total Gross Profit: $337.76 million
  • Total Operating Expenses: $174.10 million
How has Afya revenue changed over the last 7 years?

Over the last 7 years, Afya's total revenue changed from $65.22 million in 2017 to $534.34 million in 2024, a change of 719.3%.

How much debt does Afya have?

Afya's total liabilities were at $730.75 million at the end of 2024, a 10.0% decrease from 2023, and a 764.3% increase since 2018.

How much cash does Afya have?

In the past 6 years, Afya's cash and equivalents has ranged from $16.04 million in 2018 to $234.69 million in 2019, and is currently $147.32 million as of their latest financial filing in 2024.

How has Afya's book value per share changed over the last 7 years?

Over the last 7 years, Afya's book value per share changed from 0.00 in 2017 to 7.37 in 2024, a change of 736.7%.


Related Companies

This page (NASDAQ:AFYA) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
As Bitcoin supply vanishes, this Trump-aligned token could explode
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...
Brownstone Research | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored